The Discounted Cash Flow (DCF) valuation of Jacobson Pharma Corporation Ltd (2633.HK) is 2.14 HKD. With the latest stock price at 1.21 HKD, the upside of Jacobson Pharma Corporation Ltd based on DCF is 76.6%.
Based on the latest price of 1.21 HKD and our DCF valuation, Jacobson Pharma Corporation Ltd (2633.HK) is a buy. buying 2633.HK stocks now will result in a potential gain of 76.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.9% | 7.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 1.63 - 3.11 | 2.14 |
| Upside | 34.5% - 157.0% | 76.6% |